Alvotech (ALVO) Operating Margin Growth (3y) (2025 - 2026)

Alvotech (ALVO) Operating Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 1,673.00
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -37.00
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -5,395.00
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -1,442.00
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -1,299.00
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 5,091.00
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 5,193.00
10 Alvotech 907.91 Mn 907.91 Mn 5.09 Mn 62,577.00

Historic Data

Download Data
DateValue
Mar 31, 2026 62,577.00
Dec 31, 2025 330,554.00
Jun 30, 2025 376,428.00
Mar 31, 2025 1.61 Mn